查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1980191

自行注射裝置市場規模、佔有率、成長及全球產業分析：按類型、應用和地區分類的洞察，2026-2034 年預測

Self-Injection Device Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 172 Pages | 商品交期: 請詢問到貨日

價格

自行注射設備市場的成長要素

2025年全球自行注射設備市場價值為48.8億美元，預計2026年將成長至55.2億美元。到2034年，該市場預計將達到151.1億美元，從2026年到2034年將維持13.42%的強勁複合年成長率。

到2025年，北美將引領市場，佔全球40.75%的市場。這得益於先進的醫療保健基礎設施、創新藥物輸送系統的高滲透率，以及Ypsomed AG、SHL Medical AG和BD等主要企業的存在。

自行注射裝置使患者無需醫護人員協助即可自行給藥。這些裝置包括筆式注射器、自動注射器、無針注射器和穿戴式注射器。它們廣泛用於治療糖尿病、類風濕性關節炎、多發性硬化症、過敏性休克和心血管疾病等慢性疾病。

市場促進因素

慢性病盛行率增加

糖尿病和自體免疫疾病負擔日益加重是成長要素。由於長期疾病需要頻繁用藥，自行注射裝置提供了一種便捷有效的解決方案。人口老化進一步增加了市場需求，而老年患者往往更傾向於居家治療方法。

技術進步

藥物輸送技術的持續創新正顯著推動市場擴張。現代自動注射器採用符合人體工學的設計，具備一鍵操作、自動針頭回縮、劑量確認訊號和電子劑量記錄功能。電子機械和連網型設備的開發提高了病患的用藥依從性和安全性。

患者越來越傾向於自行給藥

由於其便利性、減少就醫次數和提高生活品質，患者越來越傾向於自行給藥。自行注射裝置也有助於提高治療順從性，並減輕醫療保健系統的負擔。

市場限制因素

儘管成長勢頭強勁，但仍存在一些挑戰：

  • 低收入和中等收入國家難以獲得先進設備
  • 高階設備（例如穿戴式自動注射器）高成本
  • 缺乏適當訓練和設備操作不當會造成安全隱患。
  • 全球市場監管的複雜性和核准流程的漫長。

這些因素可能會限制其在對成本敏感地區的普及。

市場機遇

製藥公司與醫療設備製造商之間日益密切的合作正在創造高盈利的成長機會。預計在預測期內，醫藥與醫療設備整合產品的開發，以及整合數位監測技術的智慧注射器的研發，將加速這些產品的普及應用。

用於大容量生物製藥和生物相似藥的穿戴式注射器正在成為一個重要的機會領域。

市場區隔分析

依產品類型

市場細分包括筆式注射器、自動注射器、無針注射器和穿戴式注射器。

  • 2024 年，筆式注射器佔了最大的市場佔有率，並且由於其使用方便，在糖尿病管理中應用廣泛，預計到 2026 年，筆式注射器將以 67.10% 的市場佔有率佔主導地位。
  • 由於自動注射器在緊急情況下能夠快速給藥，因此預計其市場將顯著成長。
  • 穿戴式注射器因其能夠持續、可控制地給藥，需求量日益成長。

依管理類型

  • 2024 年，患者自控劑量細分市場引領市場，預計到 2026 年將佔市場佔有率的 92.10%，這主要得益於其可自訂性和便利性。
  • 由於監管部門的核准不斷增加，預計體表給藥系統將穩定成長。

按類型

  • 一次性醫療器材正在推動市場發展，這得益於對過敏和糖尿病治療的高需求，預計到 2026 年，一次性醫療器材將佔全球市場佔有率的 94.55%。
  • 可重複使用的設備因其環境效益和成本效益而備受關注。

透過使用

  • 糖尿病領域正在推動市場發展，預計到 2026 年將佔市場佔有率的 70.49%。
  • 由於類風濕性關節炎和多發性硬化症病例數量不斷增加，自體免疫疾病成為第二大類疾病。

最終用戶

到 2024 年，製藥和生物技術公司將佔最大的市場佔有率，這得益於藥物和醫療設備聯合治療的策略聯盟的支持。

區域趨勢

北美洲

北美市場規模在2025年達到19.9億美元，由於疾病高發和研發投入強勁，持續維持其市場主導地位。預計美國市場規模將在2026年達到21.7億美元。

歐洲

歐洲佔第二大市場佔有率，主要得益於創新產品的推出和慢性病盛行率的上升。

亞太地區

亞太地區預計將成為成長最快的地區，主要受中國、印度和日本糖尿病盛行率上升的推動。預計2026年，日本市場規模將達3.1億美元，中國3.9億美元，印度1.1億美元。

拉丁美洲、中東和非洲

預計這些地區將逐步成長，這得益於人們意識的提高和醫療基礎設施的逐步發展。

目錄

第1章：引言

第2章摘要整理

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第4章：主要考慮因素

  • 主要疾病流行情形：依主要國家分類，2025 年
  • 概述：自行注射裝置
  • 自行注射裝置的技術進步
  • 新產品發布：按主要企業分類
  • 產業主要趨勢：併購、合作等。
  • 新冠疫情對市場的影響

第5章：全球自行注射設備市場分析、洞察與預測（2021-2034年）

  • 市場分析、洞察與預測：按產品類型分類
    • 筆式注射器
    • 自我注射器
    • 無針注射器
    • 穿戴式注射器
  • 市場分析、洞察與預測：按劑型分類
    • 表面管理
    • 患者自控給藥
  • 市場分析、洞察與預測：按類型
    • 一次性的
    • 可重複使用的
  • 市場分析、洞察與預測：按應用領域分類
    • 自體免疫疾病
    • 糖尿病
    • 疼痛管理
    • 其他
  • 市場分析、洞察與預測：按最終用戶分類
    • 製藥和生物技術公司
    • 委託研究與製造組織（CRMO）
  • 市場分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美自行注射裝置市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲自行注射設備市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太地區自行注射設備市場分析、洞察與預測（2021-2034年）

  • 國家
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲自行注射裝置市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章：中東和非洲自行注射設備市場分析、洞察與預測（2021-2034年）

  • 國家
    • GCC
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • SHL Medical AG
    • BD
    • Crossject
    • PharmaJet
    • Ypsomed AG
    • Owen Mumford Limited
    • Recipharm AB
    • Gerresheimer AG
    • Halozyme Inc.
Product Code: FBI107873

Growth Factors of self-injection device Market

The global self-injection device market was valued at USD 4.88 billion in 2025 and is projected to grow to USD 5.52 billion in 2026. The market is expected to reach USD 15.11 billion by 2034, registering a strong CAGR of 13.42% during 2026-2034.

North America dominated the market in 2025, accounting for 40.75% of the global share, supported by advanced healthcare infrastructure, high adoption of innovative drug delivery systems, and the presence of leading companies such as Ypsomed AG, SHL Medical AG, and BD.

Self-injection devices enable patients to administer medications independently without the assistance of healthcare professionals. These devices include pen injectors, autoinjectors, needle-free injectors, and wearable injectors. They are widely used for chronic conditions such as diabetes, rheumatoid arthritis, multiple sclerosis, anaphylaxis, and cardiovascular diseases.

Market Drivers

Rising Prevalence of Chronic Diseases

The increasing burden of diabetes and autoimmune disorders is a primary growth driver. Long-term diseases require frequent medication administration, making self-injection devices a convenient and effective solution. The rising geriatric population further increases demand, as elderly patients prefer home-based treatment options.

Technological Advancements

Continuous innovations in drug delivery technologies are significantly boosting market expansion. Modern autoinjectors now feature ergonomic designs, one-button activation, automatic needle retraction, dose confirmation signals, and electronic injection logs. The development of electromechanical and connected devices has enhanced patient adherence and safety.

Growing Patient Preference for Self-Administration

Patients increasingly prefer self-administration due to convenience, reduced hospital visits, and improved quality of life. Self-injection devices also improve treatment adherence and reduce healthcare system burden.

Market Restraints

Despite strong growth, certain challenges persist:

  • Limited availability of advanced devices in low- and middle-income countries.
  • High costs of premium devices such as wearable autoinjectors.
  • Safety concerns and improper device handling without adequate training.
  • Regulatory complexities and lengthy approval processes in global markets.

These factors may restrict adoption in cost-sensitive regions.

Market Opportunities

Increasing collaborations between pharmaceutical companies and device manufacturers are creating lucrative growth opportunities. The development of drug-device combination products and smart injectors integrated with digital monitoring technologies is expected to accelerate adoption during the forecast period.

Wearable injectors for large-volume biologics and biosimilars are emerging as a major opportunity area.

Market Segmentation Analysis

By Product Type

The market is segmented into pen injectors, autoinjectors, needle-free injectors, and wearable injectors.

  • Pen injectors held the largest share in 2024 and are projected to dominate with 67.10% share in 2026, owing to their ease of use and widespread diabetes management applications.
  • Autoinjectors are expected to grow at a notable rate due to rapid emergency drug delivery benefits.
  • Wearable injectors are witnessing rising demand for prolonged and controlled drug administration.

By Delivery Type

  • The patient-controlled delivery segment dominated in 2024 and is projected to account for 92.10% of the market share in 2026, driven by customization and convenience.
  • On-body delivery systems are expected to grow steadily due to increasing regulatory approvals.

By Type

  • Disposable devices led the market and are expected to contribute 94.55% of the global share in 2026, supported by high demand for allergy and diabetes treatments.
  • Reusable devices are gaining traction due to environmental and cost benefits.

By Application

  • The diabetes segment dominated and is expected to account for 70.49% of the market share in 2026.
  • Autoimmune disorders represent the second-largest segment due to rising rheumatoid arthritis and multiple sclerosis cases.

By End-User

Pharmaceutical and biotechnology companies held the largest share in 2024, supported by strategic collaborations for drug-device combination therapies.

Regional Insights

North America

North America generated USD 1.99 billion in 2025 and maintained dominance due to high disease prevalence and strong R&D investments. The U.S. market is projected to reach USD 2.17 billion in 2026.

Europe

Europe holds the second-largest share, driven by innovative product launches and increasing chronic disease incidence.

Asia Pacific

Asia Pacific is projected to witness the fastest growth, supported by rising diabetes prevalence in China, India, and Japan. Japan's market is forecast to reach USD 0.31 billion in 2026, China USD 0.39 billion, and India USD 0.11 billion.

Latin America & Middle East & Africa

These regions are expected to grow at a moderate pace, driven by increasing awareness and gradual healthcare infrastructure improvements.

Competitive Landscape

The market is competitive and innovation-driven. Leading players include BD, Ypsomed AG, and SHL Medical AG, along with companies such as Gerresheimer AG, Owen Mumford Limited, PharmaJet, Crossject, and Halozyme Inc. Strategic collaborations, new product launches, and regulatory approvals are key competitive strategies.

Conclusion

The global self-injection device market is positioned for robust expansion from USD 4.88 billion in 2025 to USD 15.11 billion by 2034, growing at a CAGR of 13.42%. Rising chronic disease prevalence, strong technological advancements, increasing patient preference for home-based care, and strategic industry collaborations are major growth catalysts. While cost and regulatory challenges remain, continuous innovation and expanding healthcare access are expected to sustain long-term market growth worldwide.

Segmentation By Product Type, Delivery Type, Type, Application, End-user , and Region

By Product Type * Pen Injectors

  • Autoinjectors
  • Needle Free Injectors
  • Wearable Injectors

By Delivery Type * On body Delivery

  • Patient Controlled Delivery

By Type * Disposable

  • Reusable

By Application * Autoimmune Disorders

  • Diabetes
  • Pain Management
  • Others

By End-user * Pharmaceutical & Biotechnology Companies

  • Contract Research & Manufacturing Organizations

By Region * North America (By Product Type, Delivery Type, Type, Application, End-user, and Country)

    • U.S.
    • Canada
  • Europe (By Product Type, Delivery Type, Type, Application, End-user, and Country/Sub-Region)
    • Germany
    • France
    • U.K.
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product Type, Delivery Type, Type, Application, End-user, and Country/Sub-Region)
    • China
    • India
    • Japan
    • Australia
    • Southeast Asia
    • Rest of the Asia Pacific
  • Latin America (By Product Type, Delivery Type, Type, Application, End-user, and Country/Sub-Region)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (By Product Type, Delivery Type, Type, Application, End-user, and Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Diseases, By Key Countries/Regions, 2025
  • 4.2. Overview : Self Injection Devices
  • 4.3. Technological Advancements in Self Injection Devices
  • 4.4. New Product Launches, By Key Players
  • 4.5. Key Industry Developments Mergers, Acquisitions, Partnerships, etc.
  • 4.6. Impact of COVID 19 on the Market

5. Global Self-Injection Device Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Pen Injectors
    • 5.1.2. Autoinjectors
    • 5.1.3. Needle Free Injectors
    • 5.1.4. Wearable Injectors
  • 5.2. Market Analysis, Insights and Forecast - By Delivery Type
    • 5.2.1. On body Delivery
    • 5.2.2. Patient Controlled Delivery
  • 5.3. Market Analysis, Insights and Forecast - By Type
    • 5.3.1. Disposable
    • 5.3.2. Reusable
  • 5.4. Market Analysis, Insights and Forecast - By Application
    • 5.4.1. Autoimmune Disorders
    • 5.4.2. Diabetes
    • 5.4.3. Pain Management
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By End-user
    • 5.5.1. Pharmaceutical & Biotechnology Companies
    • 5.5.2. Contract Research & Manufacturing Organizations
  • 5.6. Market Analysis, Insights and Forecast - By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa

6. North America Self-Injection Device Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Pen Injectors
    • 6.1.2. Autoinjectors
    • 6.1.3. Needle Free Injectors
    • 6.1.4. Wearable Injectors
  • 6.2. Market Analysis, Insights and Forecast - By Delivery Type
    • 6.2.1. On body Delivery
    • 6.2.2. Patient Controlled Delivery
  • 6.3. Market Analysis, Insights and Forecast - By Type
    • 6.3.1. Disposable
    • 6.3.2. Reusable
  • 6.4. Market Analysis, Insights and Forecast - By Application
    • 6.4.1. Autoimmune Disorders
    • 6.4.2. Diabetes
    • 6.4.3. Pain Management
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By End-user
    • 6.5.1. Pharmaceutical & Biotechnology Companies
    • 6.5.2. Contract Research & Manufacturing Organizations
  • 6.6. Market Analysis, Insights and Forecast - By Country
    • 6.6.1. U.S.
    • 6.6.2. Canada

7. Europe Self-Injection Device Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Pen Injectors
    • 7.1.2. Autoinjectors
    • 7.1.3. Needle Free Injectors
    • 7.1.4. Wearable Injectors
  • 7.2. Market Analysis, Insights and Forecast - By Delivery Type
    • 7.2.1. On body Delivery
    • 7.2.2. Patient Controlled Delivery
  • 7.3. Market Analysis, Insights and Forecast - By Type
    • 7.3.1. Disposable
    • 7.3.2. Reusable
  • 7.4. Market Analysis, Insights and Forecast - By Application
    • 7.4.1. Autoimmune Disorders
    • 7.4.2. Diabetes
    • 7.4.3. Pain Management
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By End-user
    • 7.5.1. Pharmaceutical & Biotechnology Companies
    • 7.5.2. Contract Research & Manufacturing Organizations
  • 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.6.1. U.K.
    • 7.6.2. Germany
    • 7.6.3. France
    • 7.6.4. Italy
    • 7.6.5. Spain
    • 7.6.6. Scandinavia
    • 7.6.7. Rest of Europe

8. Asia Pacific Self-Injection Device Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Pen Injectors
    • 8.1.2. Autoinjectors
    • 8.1.3. Needle Free Injectors
    • 8.1.4. Wearable Injectors
  • 8.2. Market Analysis, Insights and Forecast - By Delivery Type
    • 8.2.1. On body Delivery
    • 8.2.2. Patient Controlled Delivery
  • 8.3. Market Analysis, Insights and Forecast - By Type
    • 8.3.1. Disposable
    • 8.3.2. Reusable
  • 8.4. Market Analysis, Insights and Forecast - By Application
    • 8.4.1. Autoimmune Disorders
    • 8.4.2. Diabetes
    • 8.4.3. Pain Management
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By End-user
    • 8.5.1. Pharmaceutical & Biotechnology Companies
    • 8.5.2. Contract Research & Manufacturing Organizations
  • 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. Australia
    • 8.6.5. Southeast Asia
    • 8.6.6. Rest of Asia Pacific

9. Latin America Self-Injection Device Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Pen Injectors
    • 9.1.2. Autoinjectors
    • 9.1.3. Needle Free Injectors
    • 9.1.4. Wearable Injectors
  • 9.2. Market Analysis, Insights and Forecast - By Delivery Type
    • 9.2.1. On body Delivery
    • 9.2.2. Patient Controlled Delivery
  • 9.3. Market Analysis, Insights and Forecast - By Type
    • 9.3.1. Disposable
    • 9.3.2. Reusable
  • 9.4. Market Analysis, Insights and Forecast - By Application
    • 9.4.1. Autoimmune Disorders
    • 9.4.2. Diabetes
    • 9.4.3. Pain Management
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By End-user
    • 9.5.1. Pharmaceutical & Biotechnology Companies
    • 9.5.2. Contract Research & Manufacturing Organizations
  • 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.6.1. Brazil
    • 9.6.2. Mexico
    • 9.6.3. Rest of Latin America

10. Middle East & Africa Self-Injection Device Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Pen Injectors
    • 10.1.2. Autoinjectors
    • 10.1.3. Needle Free Injectors
    • 10.1.4. Wearable Injectors
  • 10.2. Market Analysis, Insights and Forecast - By Delivery Type
    • 10.2.1. On body Delivery
    • 10.2.2. Patient Controlled Delivery
  • 10.3. Market Analysis, Insights and Forecast - By Type
    • 10.3.1. Disposable
    • 10.3.2. Reusable
  • 10.4. Market Analysis, Insights and Forecast - By Application
    • 10.4.1. Autoimmune Disorders
    • 10.4.2. Diabetes
    • 10.4.3. Pain Management
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By End-user
    • 10.5.1. Pharmaceutical & Biotechnology Companies
    • 10.5.2. Contract Research & Manufacturing Organizations
  • 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.6.1. GCC
    • 10.6.2. South Africa
    • 10.6.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
    • 11.2.1. SHL Medical AG
    • 11.2.2. BD
    • 11.2.3. Crossject
    • 11.2.4. PharmaJet
    • 11.2.5. Ypsomed AG
    • 11.2.6. Owen Mumford Limited
    • 11.2.7. Recipharm AB
    • 11.2.8. Gerresheimer AG
    • 11.2.9. Halozyme Inc.

List of Tables

  • Table 1: Global Self-Injection Device Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 2: Global Self-Injection Device Market Revenue (USD billion) Forecast, by Delivery Type, 2021-2034
  • Table 3: Global Self-Injection Device Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 4: Global Self-Injection Device Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 5: Global Self-Injection Device Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 6: Global Self-Injection Device Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 7: North America Self-Injection Device Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 8: North America Self-Injection Device Market Revenue (USD billion) Forecast, by Delivery Type, 2021-2034
  • Table 9: North America Self-Injection Device Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 10: North America Self-Injection Device Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 11: North America Self-Injection Device Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 12: North America Self-Injection Device Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 13: Europe Self-Injection Device Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 14: Europe Self-Injection Device Market Revenue (USD billion) Forecast, by Delivery Type, 2021-2034
  • Table 15: Europe Self-Injection Device Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 16: Europe Self-Injection Device Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 17: Europe Self-Injection Device Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 18: Europe Self-Injection Device Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 19: Asia Pacific Self-Injection Device Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 20: Asia Pacific Self-Injection Device Market Revenue (USD billion) Forecast, by Delivery Type, 2021-2034
  • Table 21: Asia Pacific Self-Injection Device Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 22: Asia Pacific Self-Injection Device Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 23: Asia Pacific Self-Injection Device Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 24: Asia Pacific Self-Injection Device Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 25: Latin America Self-Injection Device Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 26: Latin America Self-Injection Device Market Revenue (USD billion) Forecast, by Delivery Type, 2021-2034
  • Table 27: Latin America Self-Injection Device Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 28: Latin America Self-Injection Device Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 29: Latin America Self-Injection Device Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 30: Latin America Self-Injection Device Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 31: Middle East & Africa Self-Injection Device Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 32: Middle East & Africa Self-Injection Device Market Revenue (USD billion) Forecast, by Delivery Type, 2021-2034
  • Table 33: Middle East & Africa Self-Injection Device Market Revenue (USD billion) Forecast, by Type, 2021-2034
  • Table 34: Middle East & Africa Self-Injection Device Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 35: Middle East & Africa Self-Injection Device Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 36: Middle East & Africa Self-Injection Device Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Self-Injection Device Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Self-Injection Device Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 3: Global Self-Injection Device Market Value Share (%), by Delivery Type, 2025 & 2034
  • Figure 4: Global Self-Injection Device Market Value Share (%), by Type, 2025 & 2034
  • Figure 5: Global Self-Injection Device Market Value Share (%), by Application, 2025 & 2034
  • Figure 6: Global Self-Injection Device Market Value Share (%), by End-user, 2025 & 2034
  • Figure 7: Global Self-Injection Device Market Value (USD billion), by Region, 2025 & 2034
  • Figure 8: North America Self-Injection Device Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 9: North America Self-Injection Device Market Value Share (%), by Product Type, 2025
  • Figure 10: North America Self-Injection Device Market Value (USD billion), by Delivery Type, 2025 & 2034
  • Figure 11: North America Self-Injection Device Market Value Share (%), by Delivery Type, 2025
  • Figure 12: North America Self-Injection Device Market Value (USD billion), by Type, 2025 & 2034
  • Figure 13: North America Self-Injection Device Market Value Share (%), by Type, 2025
  • Figure 14: North America Self-Injection Device Market Value (USD billion), by Application, 2025 & 2034
  • Figure 15: North America Self-Injection Device Market Value Share (%), by Application, 2025
  • Figure 16: North America Self-Injection Device Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 17: North America Self-Injection Device Market Value Share (%), by End-user, 2025
  • Figure 18: North America Self-Injection Device Market Value (USD billion), By Country, 2025 & 2034
  • Figure 19: North America Self-Injection Device Market Value Share (%), By Country, 2025
  • Figure 20: Europe Self-Injection Device Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 21: Europe Self-Injection Device Market Value Share (%), by Product Type, 2025
  • Figure 22: Europe Self-Injection Device Market Value (USD billion), by Delivery Type, 2025 & 2034
  • Figure 23: Europe Self-Injection Device Market Value Share (%), by Delivery Type, 2025
  • Figure 24: Europe Self-Injection Device Market Value (USD billion), by Type, 2025 & 2034
  • Figure 25: Europe Self-Injection Device Market Value Share (%), by Type, 2025
  • Figure 26: Europe Self-Injection Device Market Value (USD billion), by Application, 2025 & 2034
  • Figure 27: Europe Self-Injection Device Market Value Share (%), by Application, 2025
  • Figure 28: Europe Self-Injection Device Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 29: Europe Self-Injection Device Market Value Share (%), by End-user, 2025
  • Figure 30: Europe Self-Injection Device Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 31: Europe Self-Injection Device Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 32: Asia Pacific Self-Injection Device Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 33: Asia Pacific Self-Injection Device Market Value Share (%), by Product Type, 2025
  • Figure 34: Asia Pacific Self-Injection Device Market Value (USD billion), by Delivery Type, 2025 & 2034
  • Figure 35: Asia Pacific Self-Injection Device Market Value Share (%), by Delivery Type, 2025
  • Figure 36: Asia Pacific Self-Injection Device Market Value (USD billion), by Type, 2025 & 2034
  • Figure 37: Asia Pacific Self-Injection Device Market Value Share (%), by Type, 2025
  • Figure 38: Asia Pacific Self-Injection Device Market Value (USD billion), by Application, 2025 & 2034
  • Figure 39: Asia Pacific Self-Injection Device Market Value Share (%), by Application, 2025
  • Figure 40: Asia Pacific Self-Injection Device Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 41: Asia Pacific Self-Injection Device Market Value Share (%), by End-user, 2025
  • Figure 42: Asia Pacific Self-Injection Device Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 43: Asia Pacific Self-Injection Device Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 44: Latin America Self-Injection Device Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 45: Latin America Self-Injection Device Market Value Share (%), by Product Type, 2025
  • Figure 46: Latin America Self-Injection Device Market Value (USD billion), by Delivery Type, 2025 & 2034
  • Figure 47: Latin America Self-Injection Device Market Value Share (%), by Delivery Type, 2025
  • Figure 48: Latin America Self-Injection Device Market Value (USD billion), by Type, 2025 & 2034
  • Figure 49: Latin America Self-Injection Device Market Value Share (%), by Type, 2025
  • Figure 50: Latin America Self-Injection Device Market Value (USD billion), by Application, 2025 & 2034
  • Figure 51: Latin America Self-Injection Device Market Value Share (%), by Application, 2025
  • Figure 52: Latin America Self-Injection Device Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 53: Latin America Self-Injection Device Market Value Share (%), by End-user, 2025
  • Figure 54: Latin America Self-Injection Device Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 55: Latin America Self-Injection Device Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 56: Middle East & Africa Self-Injection Device Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 57: Middle East & Africa Self-Injection Device Market Value Share (%), by Product Type, 2025
  • Figure 58: Middle East & Africa Self-Injection Device Market Value (USD billion), by Delivery Type, 2025 & 2034
  • Figure 59: Middle East & Africa Self-Injection Device Market Value Share (%), by Delivery Type, 2025
  • Figure 60: Middle East & Africa Self-Injection Device Market Value (USD billion), by Type, 2025 & 2034
  • Figure 61: Middle East & Africa Self-Injection Device Market Value Share (%), by Type, 2025
  • Figure 62: Middle East & Africa Self-Injection Device Market Value (USD billion), by Application, 2025 & 2034
  • Figure 63: Middle East & Africa Self-Injection Device Market Value Share (%), by Application, 2025
  • Figure 64: Middle East & Africa Self-Injection Device Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 65: Middle East & Africa Self-Injection Device Market Value Share (%), by End-user, 2025
  • Figure 66: Middle East & Africa Self-Injection Device Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 67: Middle East & Africa Self-Injection Device Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 68: Global Self-Injection Device Market Share (%), By Company, 2025